We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,477

IP in depth: patentable biotechnology a comparative analysis of key markets
  • Fisher Adams Kelly Callinans
  • Australia, European Union, New Zealand, USA
  • March 31 2015

There is extraordinary complexity and optimization underlying even comparatively 'simple' organisms. These powerful biological products and processes


Pharmaceutical & medical device regulatory update, vol. II, issue 8
  • Jones Day
  • European Union, USA
  • April 24 2015

The first U.S. biosimilar product Zarxio overcame another legal challenge earlier this month when a federal court in California denied a motion to


Food, dietary supplement & cosmetics regulatory update volume II, issue 13
  • Jones Day
  • Canada, European Union, USA
  • June 24 2015

Last week, FDA finalized its determination that partially hydrogenated oils ("PHOs") are not "generally recognized as safe" ("GRAS") for use in human


New product liability and jurisdictional questions in e-health
  • Freshfields Bruckhaus Deringer LLP
  • Asia-Pacific, European Union, USA
  • June 2 2015

The increasing use of e-health products and services as a diagnostic and information tool raises various issues concerning potential liability if


Antitrust enforcement in the medical device sector - ten areas of focus in 2015
  • Sidley Austin LLP
  • China, European Union, USA
  • February 18 2015

Enforcement agencies and courts in the United States and Europe have long dealt with high-profile antitrust cases in the pharmaceutical sector


Sidley Austin LLP global pricing newsletter - volume three 2014
  • Sidley Austin LLP
  • Brazil, Canada, China, European Union, France, Germany, India, United Kingdom, USA
  • April 15 2014

On October 21, 2013, Brazil’s National Agency of Supplemental Health enacted Normative Resolution 388, which mandated that all private healthcare


Kartellrechtliche fallstricke im life science-bereich
  • Baker & McKenzie
  • European Union, France, USA
  • May 24 2013

Im Wettbewerb gegen Generika ist Vorsicht geboten: Verschiedene Maßnahmen gegen den Markteintritt kostengünstigerer Generika werden


Universities abroad experiment with no-fee licensing to drive biotech partnerships
  • Shook Hardy & Bacon LLP
  • Australia, Canada, European Union, United Kingdom, USA
  • May 16 2013

Universities in Australia, Canada, Europe, and the United Kingdom have reportedly embraced a 2010 Glasgow University initiative under which companies


Food, dietary supplement & cosmetics regulatory update, vol. II, issue 5
  • Jones Day
  • European Union, United Kingdom, USA
  • March 5 2015

The Dietary Guidelines Advisory Committee ("DGAC") recently released the Scientific Report of the 2015 Dietary Guidelines for Americans (the "Advisory


Biosimilars are regulated differently in China
  • Ropes & Gray LLP
  • China, European Union, USA
  • July 22 2015

The Centre for Drug Evaluation (CDE) the technical review body under the China Food and Drug Administration (CFDA) released the Technical